553,268 Shares in Septerna, Inc. (NASDAQ:SEPN) Bought by Casdin Capital LLC

Casdin Capital LLC purchased a new stake in shares of Septerna, Inc. (NASDAQ:SEPN - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 553,268 shares of the company's stock, valued at approximately $12,670,000. Septerna accounts for 0.8% of Casdin Capital LLC's portfolio, making the stock its 20th largest holding. Casdin Capital LLC owned approximately 1.25% of Septerna at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. BVF Inc. IL purchased a new position in Septerna in the fourth quarter valued at approximately $56,151,000. Bank of America Corp DE acquired a new position in shares of Septerna during the 4th quarter valued at $1,803,000. BNP Paribas Financial Markets acquired a new position in shares of Septerna during the 4th quarter valued at $52,000. Alyeska Investment Group L.P. purchased a new stake in Septerna during the 4th quarter worth $802,000. Finally, ArrowMark Colorado Holdings LLC acquired a new stake in Septerna in the 4th quarter valued at $3,387,000.

Analyst Ratings Changes

SEPN has been the subject of several analyst reports. Wells Fargo & Company decreased their target price on Septerna from $14.00 to $11.00 and set an "equal weight" rating for the company in a research report on Friday, March 28th. Cantor Fitzgerald restated an "overweight" rating and issued a $50.00 price target on shares of Septerna in a report on Tuesday, February 11th.

Insider Buying and Selling

In other news, Director Alan Ezekowitz purchased 7,491 shares of the stock in a transaction dated Tuesday, March 4th. The stock was acquired at an average cost of $6.35 per share, for a total transaction of $47,567.85. Following the acquisition, the director now owns 24,911 shares of the company's stock, valued at $158,184.85. The trade was a 43.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Gil M. Labrucherie acquired 5,000 shares of Septerna stock in a transaction that occurred on Friday, February 21st. The shares were purchased at an average price of $5.85 per share, for a total transaction of $29,250.00. Following the completion of the purchase, the chief financial officer now directly owns 30,000 shares of the company's stock, valued at $175,500. The trade was a 20.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 74,346 shares of company stock worth $439,670.

Septerna Price Performance

NASDAQ:SEPN opened at $7.16 on Tuesday. The firm has a 50-day moving average price of $6.12. Septerna, Inc. has a 1-year low of $4.17 and a 1-year high of $28.99.

Septerna (NASDAQ:SEPN - Get Free Report) last issued its quarterly earnings data on Thursday, March 27th. The company reported ($0.64) earnings per share for the quarter, beating analysts' consensus estimates of ($0.69) by $0.05. The business had revenue of $0.21 million for the quarter, compared to analyst estimates of $0.13 million. As a group, sell-side analysts expect that Septerna, Inc. will post -7.11 earnings per share for the current fiscal year.

Septerna Profile

We are a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by our proprietary Native Complex Platform™. Our industrial-scale platform aims to unlock the full potential of GPCR therapies and has led to the discovery and development of our deep pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.

Want to see what other hedge funds are holding SEPN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Septerna, Inc. (NASDAQ:SEPN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.